About Overland Pharmaceuticals
Overland Pharmaceuticals is a company based in Boston (United States) founded in 2020 by Ed Zhang and Hua Mu. Its chief executive is Hua Mu. Similar companies include Be Bio, Immusoft, JW Therapeutics and Cellective BioTherapy; 4 of its 4 listed similar companies have raised funding.
- Headquarters Boston, United States
- Founders Ed Zhang, Hua Mu
- Website overlandpharma.com
People of Overland Pharmaceuticals
12 people are tracked at Overland Pharmaceuticals (8 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Ed Zhang | Co-Founder, COO | Leadership |
Hua Mu | Co-Founder, CEO | Leadership |
Weijie Lan | Vp, Cell Therapy Platform Research | Leadership |
Weimin Li | Vp, Head Of Translational Medicine And Pre-clinical Research | Leadership |
Chia-Wei Chang | Director, Cell Therapy, Car-t Product Development | Leadership |
Eric H. | Head Of US Operations | Leadership |
Sophie Chen | Head Of Legal And Compliance | Leadership |
Yi-Shin Lai | Director, Cell Engineering And Product Development | Leadership |
Audrey Hollingsworth | Scientist | Team |
Robert Teachenor | Scientist/lab Manager | Team |
Wendy Yang | Corporate Development And Strategy | Team |
Arpita Pal | Senior Scientist | Team |
Complete people profiles for Overland Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Overland Pharmaceuticals
Overland Pharmaceuticals has 4 listed similar companies in our database, 4 of them funded. They include Be Bio, Immusoft, JW Therapeutics and Cellective BioTherapy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| be.bio | 2020 | Cambridge, United States | $356M | – | B cell therapies are developed for oncology and rare diseases. | |
| immusoft.com | 2009 | Seattle, United States | $44.13M | – | B cells are programmed as biofactories for therapeutic protein delivery. | |
| jwtherapeutics.com | 2016 | Shanghai, China | $195.55M | – | Cell immunotherapy products are developed for cancer treatment. | |
| cellectivebiotherapy.com | 2015 | Durham, United States | $2.5M | – | B cell-based therapies are developed for autoimmunity, immunodeficiency, and cancers. |
Detailed similar companies of Overland Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Overland Pharmaceuticals
Complete news archive for Overland Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Overland Pharmaceuticals
Overland Pharmaceuticals was founded in 2020.
Overland Pharmaceuticals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Hua Mu is the current CEO of Overland Pharmaceuticals. They have also founded this company.
Overland Pharmaceuticals's top competitors include Be Bio, Immusoft and JW Therapeutics.